Meeting Agenda for the Advisory Committee on Breast Cancer in Young Women

View Printable Version pdf icon[PDF-171KB]

Meeting Objectives

To advise the Secretary of the Department of Health and Human Services (HHS) and the Director of the Centers for Disease Control and Prevention (CDC) regarding the formative research, development, implementation, and evaluation of evidence-based activities designed to prevent breast cancer in young women (particularly among those at heightened risk).

Upcoming Meeting: Friday, November 20, 2020

8:00 – 8:15 a.m.

Opening: Welcome, Roll Call, and Introductions

Jeremy McCallister
Designated Federal Officer, DCPC, CDC

Elana Silber, MBA
ACBCYW Committee Chair

8:15 – 8:30 a.m.

CDC Updates

Temeika L. Fairley, PhD
Senior Health Scientist, DCPC, CDC

8:30 – 9:15 a.m.

Barriers to Care Presentation

Lisa Schlager
Facing Our Risk of Cancer Empowered (FORCE)
Vice President, Public Policy

9:15 – 10:45 a.m.

Work Group Reports and Discussion

Genetics & Genomics Workgroup
Shubhada Dhage, MD, FACS
NYU Perlmutter Cancer Center

Joyce Tannenbaum Turner, MS, CGC
Children’s National Medical Center

Mental/Behavioral Health Workgroup
Mylin Torres, MD
Winship Cancer Institute

Michele Maria Cerullo, JD
DaVita Medical Group

Provider Workgroup
Lindsay Avner
Bright Pink

Kenneth Lin, MD, MPH
Georgetown University Medical Center

Sexual Health Workgroup
Lisa Astalos Chism, DNP, APRN, NCMP, FAANP
Oakland Macomb Obstetrics & Gynecology Associates

Ellyn Davidson
Brogan & Partners

10:45 – 11:00 a.m.


11:00 a.m. – 12:15 p.m.

ACBCYW Open Discussion 

Elana Silber, MBA
ACBCYW Committee Chair

12:15 – 12:30 p.m.

Public Comment

12:30 – 1:00 p.m.

Summary and Closing

Elana Silber, MBA
ACBCYW Committee Chair

View Page In:pdf icon PDF [171K]
Page last reviewed: November 16, 2020